[1]杨婷婷,林 青,黄 莹,等.中等长度导管及经外周静脉置入中心静脉导管静脉炎发生率的Meta分析[J].医学信息,2024,37(22):15-21.[doi:10.3969/j.issn.1006-1959.2024.22.004]
 YANG Tingting,LIN Qing,HUANG Ying,et al.Meta-analysis of the Incidence of Phlebitis in Midline Catheter and Peripherally Inserted Central Catheter[J].Journal of Medical Information,2024,37(22):15-21.[doi:10.3969/j.issn.1006-1959.2024.22.004]
点击复制

中等长度导管及经外周静脉置入中心静脉导管静脉炎发生率的Meta分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年22期
页码:
15-21
栏目:
医学数据科学
出版日期:
2024-11-15

文章信息/Info

Title:
Meta-analysis of the Incidence of Phlebitis in Midline Catheter and Peripherally Inserted Central Catheter
文章编号:
1006-1959(2024)22-0015-07
作者:
杨婷婷1林 青2黄 莹1翁菲菲3
1.安徽中医药大学护理学院,安徽 合肥 230031;2.安徽中医药大学第一附属医院护理部,安徽 合肥 230031;3.安徽中医药大学第一附属医院肿瘤科,安徽 合肥 230031
Author(s):
YANG Tingting1LIN Qing2HUANG Ying1WENG Feifei3
1.College of Nursing,Anhui University of Chinese Medicine,Hefei 230031,Anhui,China;2.Nursing Department of the First Affiliated Hospital of Anhui University of Chinese Medicine,Hefei 230031,Anhui,China; 3.Department of Oncology,the First Affiliated Hospital of Anhui University of Chinese Medicine,Hefei 230031,Anhui,China
关键词:
中等长度导管经外周静脉置入中心静脉导管静脉炎
Keywords:
Midline catheterPeripherally inserted central catheterPhlebitis
分类号:
R472
DOI:
10.3969/j.issn.1006-1959.2024.22.004
文献标志码:
A
摘要:
目的 系统评价在静脉输液过程中患者应用中等长度导管(MC)与经外周静脉置入中心静脉导管(PICC)静脉炎的发生情况。方法 计算机检索Web of Science、PubMed、Embase、Scopus、Cochrane Library、ProQuest、CBM、中国知网、维普、万方数据库中MC与PICC静脉炎发生率的相关研究,检索时限自建库起至2023年7月。根据纳入与排除标准筛选,对符合标准的研究进行质量评价后,采用RevMan5.4软件进行Meta分析。结果 共纳入17项研究,包括2619例患者。Meta分析结果显示,MC组静脉炎发生率与PICC组相比,差异无统计学意义(RR=0.71,95%CI:0.44~1.15,P=0.17)。肿瘤患者亚组MC组静脉炎发生率低于PICC组(RR=0.34,95%CI:0.15~0.77,P=0.01),其他研究人群亚组MC组静脉炎发生率与PICC组比较,差异无统计学意义(P>0.05)。结论 在一定观察时间范围内,MC与PICC在静脉炎发生率方面无明显差别,在临床实践中,建议医护人员结合疾病情况与患者意愿,合理选择静脉血管通路装置。
Abstract:
Objective To systematically evaluate the incidence of phlebitis in patients with midline catheter (MC) and peripherally inserted central catheter (PICC) during intravenous infusion.Methods Web of Science, PubMed, Embase, Scopus, Cochrane Library, ProQuest, CBM, CNKI, VIP and Wanfang databases were searched for studies on the relationship between MC and the incidence of PICC phlebitis from the establishment of the database to July 2023. According to the inclusion and exclusion criteria, the quality of the studies that met the criteria was evaluated, and Meta-analysis was performed using RevMan5.4 software.Results A total of 17 studies were included, including 2619 patients. The results of meta-analysis showed that there was no significant difference in the incidence of phlebitis between the MC group and the PICC group (RR=0.71, 95%CI: 0.44-1.15, P=0.17); the incidence of phlebitis in the MC group was lower than that in the PICC group (RR=0.34, 95%CI: 0.15-0.77, P=0.01); there was no significant difference in the incidence of phlebitis between the MC group and the PICC group in other study population subgroups (P>0.05).Conclusion In a certain observation time range, there is no significant difference in the incidence of phlebitis between MC and PICC. Thus, in clinical practice, it is recommended that medical staff reasonably select venous vascular access devices based on disease conditions and patient wishes.

参考文献/References:

[1]张彩琳,李婷,王娟,等.复方紫草通络散外用治疗静脉留置针静脉炎的效果观察[J].甘肃医药,2023,42(6):554-556.[2]Gorski LA,Hadaway L,Hagle ME,et al.Infusion Therapy Standards of Practice, 8th Edition[J].J Infus Nurs,2021,44(1S Suppl 1):S1-S224.[3]Woller SC,Stevens SM,Evans RS.The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) initiative: A summary and review of peripherally inserted central catheter and venous catheter appropriate use[J].J Hosp Med,2016,11(4):306-310.[4]Spiegel RJ,Eraso D,Leibner E,et al.The Utility of Midline Intravenous Catheters in Critically Ill Emergency Department Patients[J].Ann Emerg Med,2020,75(4):538-545.[5]邓洪渠,曾小梅,王琴,等.分级干预在非小细胞肺癌经外周静脉穿刺的中心静脉导管置管术后的应用[J].血管与腔内血管外科杂志,2022,8(7):881-885.[6]Conoscenti E,Blot S.A necessary evil: Central venous catheters[J].Intensive Crit Care Nurs,2020,57:102810.[7]Huang Z,Chen H,Liu Z.The 100 top-cited systematic reviews/meta-analyses in central venous catheter research: A PRISMA-compliant systematic literature review and bibliometric analysis[J].Intensive Crit Care Nurs,2020,57:102803.[8]Stang A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J].Eur J Epidemiol,2010,25(9):603-605.[9]Higgins JP,Altman DG,G?准tzsche PC,et al.The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials[J].BMJ,2011,343:d5928.[10]Caparas JV,Hu JP.Safe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical trial[J].J Vasc Access,2014,15(4):251-256.[11]Sharp R,Esterman A,McCutcheon H,et al.The safety and efficacy of midlines compared to peripherally inserted central catheters for adult cystic fibrosis patients: a retrospective, observational study[J].Int J Nurs Stud,2014,51(5):694-702.[12]Tao F,Wang X,Liu J,et al.Perioperative application of midline catheter and PICC in Patients with gastrointestinal tumors[J].J BUON,2019,24(6):2546-2552.[13]Xu T,Kingsley L,DiNucci S,et al.Safety and utilization of peripherally inserted central catheters versus midline catheters at a large academic medical center[J].Am J Infect Control,2016,44(12):1458-1461.[14]伊秋香,伊秀英,周若霞,等.改良型中等长度导管在肝胆胰患者中的应用研究[J].赣南医学院学报,2021,41(4):396-398.[15]刘佳佳,张娟,谭蕾.改良型中等长度导管与PICC在胃肠道肿瘤患者围手术期中的应用比较[J].护理实践与研究,2018,15(7):143-145.[16]刘宗淑,宋秀荣,孔林芳,等.超声引导下改良塞丁格技术植入改良外周静脉中长导管的临床应用效果[J].中外医学研究,2019,17(35):173-175.[17]徐兵,杨丽娟,戴明红,等.中等长度导管在危重新生儿静脉输液中的应用效果[J].循证护理,2022,8(9):1276-1278.[18]朱颖,赵燕,周燕妮,等.外周中等长度导管在神经外科患者中的应用效果[J].实用临床医药杂志,2021,25(2):40-42,58.[19]李兰,李现文,蔡志云,等.意外伤害患儿上腔静脉置入20 cm中长导管的效果观察[J].护理学报,2020,27(16):52-55.[20]李冬梅,陈兰兰,韩玉婷,等.中等长度导管在神经外科病人静脉输液中的应用[J].护理研究,2018,32(24):3966-3968.[21]李彬,邓丽娜,赵蕾,等.老年住院患者静脉中长导管临床相关并发症调查[J].中国老年保健医学,2018,16(2):130,133.[22]杨美华,袁顺琼,甘秀妮,等.中长导管在急性胰腺炎患者静脉输液治疗中的临床效果观察[J].检验医学与临床,2019,16(6):729-731.[23]王晓娟,张雪雪.中长导管在感染科输液患者中的应用效果观察[J].首都食品与医药,2020,27(7):128.[24]赵敏艳,吴伶慧,刘红,等.中线导管在脑卒中重症患者中的应用效果[J].血管与腔内血管外科杂志,2021,7(11):1368-1372.[25]车肖文,唐晓莲,颜婧.晚期肿瘤静脉营养支持患者应用改良型中等长度导管与PICC效果比较[J].临床与病理杂志,2020,40(9):2341-2344.[26]高娇,李珊珊,庞湃,等.中线导管对Ⅲ期喉癌术后患者不良事件及血流变学的影响[J].中国继续医学教育,2020,12(21):168-171.[27]罗小强,龚雅利,张成,等.159例烧伤重症监护病房导管相关性血流感染患者病原菌分布及耐药性分析[J].中华烧伤杂志,2020,36(1):24-31.[28]Lee JH,Kim MU,Kim ET,et al.Prevalence and predictors of peripherally inserted central venous catheter associated bloodstream infections in cancer patients: A multicentre cohort study[J].Medicine (Baltimore),2020,99(6):e19056.[29]白吉明,张勃,李建华,等.维护教育在肿瘤患者外周中心静脉置管的应用[J].医学信息,2020,33(5):183-185.[30]杨丽娟,刘丽华,伏蕤,等.PICC置入病人并发机械性静脉炎列线图预测模型的构建[J].护理研究,2021,35(10):1746-1750.[31]曹兆铭,张会君,王迎春.PICC置管加温充气固定装置的设计和应用[J].护理学杂志,2022,37(20):57-60.[32]喻婷,刘文文.改良型中等长度导管在肠外营养患者中的应用[J].中国处方药,2019,17(1):137-138.[33]赵林芳,蔡志云,樊小朋,等.中等长度静脉导管置管不同尖端位置的效果比较[J].中华护理杂志,2022,57(5):517-524.[34]Anderson J,Greenwell A,Louderback J,et al.Comparison of Outcomes of Extended Dwell/Midline Peripheral Intravenous Catheters and Peripherally Inserted Central Catheters in Children[J].Journal of the Association for Vascular Access,2016,21(3):158-164.

更新日期/Last Update: 1900-01-01